Source: The Pharma Letter

Amplyx Pharmaceuticals: BRIEF-Amplyx in-licenses Ph II candidate from Novartis

US biotech firm Amplyx Pharmaceuticals has executed an exclusive worldwide license agreement with Swiss...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Ciara Kennedy's photo - President & CEO of Amplyx

President & CEO

Ciara Kennedy

CEO Approval Rating

89/100

Amplyx is a biotechnology company that researches, develops and commercializes novel therapeutics for the treatment of fungal infections. Read more